✦ LIBER ✦

Preclinical review of cerivastatin sodium—a step forward in HMG-CoA reductase inhibition

✍ Scribed by H. Bischoff; R. Angerbauer; M. Boberg; D. Petzinna; D. Schmidt; W. Steinke; G. Thomas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical safety evaluation of cerivas

✍ Eckhard von Keutz; Gerhard Schlüter 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 702 KB

Effects of cerivastatin sodium, a new HM

✍ Susumu Tazuma; Gunji Yamashita; Hidenori Ochi; Hiroyuki Miura; Tsuyoshi Kajihara 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 576 KB

A long-term comparative trial of cerivas

✍ Jun Sasaki; Kikuo Arakawa; Kyosuke Yamamoto; Shozo Kobori; Masato Ageta; Suminor 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 658 KB

In vitro antitumor activity of cerivasta

✍ Wojciech Feleszko; Izabela Mlynarczuk; Dominika Nowis 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Inhibition of HMG-CoA reductase with cer

✍ Scharnagl, H.; Winkler, K.; Park, S.M.; Friedrich, I.; Baumstark, M.; Wieland, H 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 133 KB

2.P.94 Reduction of plasma cholesterol l

✍ Yuji Yasunobu; Kozo Hayashi; Tetsuji Shingu; Katsuhiko Nomura; Katuhiko Nomura; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 181 KB